ROBIN PARIHAR to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications ROBIN PARIHAR has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.089
-
Phase I study of the sequential combination of interleukin-12 and interferon alfa-2b in advanced cancer: evidence for modulation of interferon signaling pathways by interleukin-12. J Clin Oncol. 2005 Dec 01; 23(34):8835-44.
Score: 0.039
-
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. Clin Cancer Res. 2002 Dec; 8(12):3718-27.
Score: 0.032
-
Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Cancer Res. 2006 Jan 01; 66(1):517-26.
Score: 0.010
-
Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection. Surgery. 2002 Aug; 132(2):205-12.
Score: 0.008